Skip to content
Aussie8 – Lifestyle
Author:
Parabilis Medicines, Inc.
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
August 29, 2026
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 13, 2026
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 11, 2026
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
June 9, 2026